📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial. (2024)

First Author: Pal S

Attributed to: Targeting the Type I interferon pathway in Neuromyelitis Optica Spectrum Disorder funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1474-4422(24)00326-0

PubMed Identifier: 39307154

Publication URI: http://europepmc.org/abstract/MED/39307154

Type: Journal Article/Review

Volume: 23

Parent Publication: The Lancet. Neurology

Issue: 11

ISSN: 1474-4422